Wellbutrin XL for Dysthymic Disorder

Status Completed

Clinical Trial Summary

This is a ten-week, double-blind study of Wellbutrin XL in outpatients with dysthymic disorder, a form of low-grade chronic depression. We hypothesize that patients taking Wellbutrin XL will show greater improvement in depression symptoms and psychosocial functioning than patients taking placebo.

Clinical Trial Description

This is a ten-week, double-blind, placebo-controlled study designed to evaluate the tolerability, dosing and efficacy of Wellbutrin XL in outpatients who meet Diagnostic and Statistical Manual-IV criteria for early onset, primary type dysthymic disorder (low-grade chronic depression). It is hypothesized that patients taking Wellbutrin XL will show greater improvement in depression symptoms and psychosocial functioning than patients taking placebo. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Dysthymic Disorder

Clinical Trial Details

NCT number	NCT00225251
Study type	Interventional
Source	St. Luke's-Roosevelt Hospital Center
Contact
Status	Completed
Phase	Phase 4
Start date	November 2004
Completion date	June 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01583400` - Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial	N/A
Recruiting	`NCT00260390` - Testosterone Replacement in Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized Trial	Phase 4
Completed	`NCT00518986` - Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression	Phase 4
Completed	`NCT04437485` - eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk	Phase 2
Completed	`NCT01892124` - Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive Symptoms	N/A
Active, not recruiting	`NCT01473615` - Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression	N/A
Completed	`NCT01542957` - Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused Intervention	N/A
Completed	`NCT00619411` - Interpersonal Psychotherapy for Depressed Adolescents and Parents	Phase 1
Recruiting	`NCT03507114` - Rumination Focus Cognitive Behavior Therapy	N/A
Recruiting	`NCT03917550` - RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression	N/A
Completed	`NCT00688818` - Quetiapine in Co-Morbid Depressive and Anxiety Disorders	N/A
Completed	`NCT00220701` - Escitalopram in the Treatment of Dysthymic Disorder, Double Blind	Phase 4
Completed	`NCT00096642` - Cognitive Behavioral Therapy for Early-Onset Depression	N/A
Completed	`NCT02458690` - eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients	Phase 2
Completed	`NCT00883519` - The Efficacy of Parent Involvement in the Treatment of Adolescent Depression	Phase 1/Phase 2
Completed	`NCT01852383` - Duloxetine Treatment in Elderly With Dysthymia	Phase 4
Completed	`NCT01561105` - Improving Depression Care for Elders: Coordinating Center	N/A
Not yet recruiting	`NCT05118594` - Testing a Precision Psychotherapy System for Low-income Patients	N/A
Completed	`NCT01537068` - Desvenlafaxine vs. Placebo Treatment of Chronic Depression	Phase 4
Completed	`NCT00073359` - Effects of Therapist Behavior on the Treatment of Depressed Adolescents	Phase 1/Phase 2